{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:40:47Z","timestamp":1761824447854},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,23]]},"DOI":"10.7759\/cureus.43966","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T10:40:31Z","timestamp":1692787231000},"source":"Crossref","is-referenced-by-count":1,"title":["Antisynthetase Syndrome With Predominant Pulmonary Involvement: A Case Report"],"prefix":"10.7759","author":[{"given":"Beatriz","family":"Lima Corr\u00eaa de Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R","family":"Victor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helo\u00edsa Maria","family":"Farias Fontes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayana Maria","family":"Caminha Mendes Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Lima Corr\u00eaa de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/CPM.0000000000000171","article-title":"The diagnosis and treatment of antisynthetase syndrome","volume":"23","author":"Witt LJ","year":"2016","unstructured":"Witt LJ, Curran JJ, Strek ME. The diagnosis and treatment of antisynthetase syndrome. Clin Pulm Med. 2016, 23:218-26. 10.1097\/CPM.0000000000000171","journal-title":"Clin Pulm Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101503","article-title":"Clinical manifestations and treatment of antisynthetase syndrome","volume":"34","author":"Marco JL","year":"2020","unstructured":"Marco JL, Collins BF. Clinical manifestations and treatment of antisynthetase syndrome. Best Pract Res Clin Rheumatol. 2020, 34:101503. 10.1016\/j.berh.2020.101503","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001144","article-title":"Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study","volume":"94","author":"Cavagna L","year":"2015","unstructured":"Cavagna L, Nu\u00f1o L, Scir\u00e8 CA, et al.. Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study. Medicine (Baltimore). 2015, 94:e1144. 10.1097\/MD.0000000000001144","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-0111-3","article-title":"Interstitial lung disease in a patient with antisynthetase syndrome and no myositis","volume":"26","author":"Plastiras SC","year":"2007","unstructured":"Plastiras SC, Soliotis FC, Vlachoyiannopoulos P, Tzelepis GE. Interstitial lung disease in a patient with antisynthetase syndrome and no myositis. Clin Rheumatol. 2007, 26:108-11. 10.1007\/s10067-005-0111-3","journal-title":"Clin Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-013-0349-8","article-title":"Clinical heterogeneity and outcomes of antisynthetase syndrome","volume":"15","author":"Hervier B","year":"2013","unstructured":"Hervier B, Benveniste O. Clinical heterogeneity and outcomes of antisynthetase syndrome. Curr Rheumatol Rep. 2013, 15:349. 10.1007\/s11926-013-0349-8","journal-title":"Curr Rheumatol Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-20-3328","article-title":"A narrative review of interstitial lung disease in anti-synthetase syndrome: a clinical approach","volume":"13","author":"Sawal N","year":"2021","unstructured":"Sawal N, Mukhopadhyay S, Rayancha S, Moore A, Garcha P, Kumar A, Kaul V. A narrative review of interstitial lung disease in anti-synthetase syndrome: a clinical approach. J Thorac Dis. 2021, 13:5556-71. 10.21037\/jtd-20-3328","journal-title":"J Thorac Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390424","article-title":"Coexistence of two antisynthetases in a patient with the antisynthetase syndrome","volume":"39","author":"Gelp\u00ed C","year":"1996","unstructured":"Gelp\u00ed C, Kanterewicz E, Gratacos J, Targoff IN, Rodr\u00edguez-S\u00e1nchez JL. Coexistence of two antisynthetases in a patient with the antisynthetase syndrome. Arthritis Rheum. 1996, 39:692-7. 10.1002\/art.1780390424","journal-title":"Arthritis Rheum"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8112013","article-title":"Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course","volume":"8","author":"Cavagna L","year":"2019","unstructured":"Cavagna L, Trallero-Aragu\u00e1s E, Meloni F, et al.. Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course. J Clin Med. 2019, 8:2013. 10.3390\/jcm8112013","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/08916930600623791","article-title":"In patients with antisynthetase syndrome the occurrence of anti-Ro\/SSA antibodies causes a more severe interstitial lung disease","volume":"39","author":"La Corte R","year":"2006","unstructured":"La Corte R, Lo Mo Naco A, Locaputo A, Dolzani F, Trotta F. In patients with antisynthetase syndrome the occurrence of anti-Ro\/SSA antibodies causes a more severe interstitial lung disease. Autoimmunity. 2006, 39:249-53. 10.1080\/08916930600623791","journal-title":"Autoimmunity"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n P","year":"2016","unstructured":"Brito-Zer\u00f3n P, Baldini C, Bootsma H, et al.. Sj\u00f6gren syndrome. Nat Rev Dis Primers. 2016, 2:16047. 10.1038\/nrdp.2016.47","journal-title":"Nat Rev Dis Primers"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors GR","year":"2010","unstructured":"Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?. Chest. 2010, 138:1464-74. 10.1378\/chest.10-0180","journal-title":"Chest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1590\/s1806-37132011000100015","article-title":"Myositis-related interstitial lung disease and antisynthetase syndrome","volume":"37","author":"Solomon J","year":"2011","unstructured":"Solomon J, Swigris JJ, Brown KK. Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol. 2011, 37:100-9. 10.1590\/s1806-37132011000100015","journal-title":"J Bras Pneumol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/8xj0b9","article-title":"Defining anti-synthetase syndrome: a systematic literature review","volume":"40","author":"Zanframundo G","year":"2022","unstructured":"Zanframundo G, Faghihi-Kashani S, Scir\u00e8 CA, et al.. Defining anti-synthetase syndrome: a systematic literature review. Clin Exp Rheumatol. 2022, 40:309-19. 10.55563\/clinexprheumatol\/8xj0b9","journal-title":"Clin Exp Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.09.020","article-title":"Antisynthetase syndrome - much more than just a myopathy","volume":"51","author":"Opinc AH","year":"2021","unstructured":"Opinc AH, Makowska JS. Antisynthetase syndrome - much more than just a myopathy. Semin Arthritis Rheum. 2021, 51:72-83. 10.1016\/j.semarthrit.2020.09.020","journal-title":"Semin Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer A","year":"2015","unstructured":"Fischer A, Antoniou KM, Brown KK, et al.. An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J. 2015, 46:976-87. 10.1183\/13993003.00150-2015","journal-title":"Eur Respir J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-012-0246-6","article-title":"Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment","volume":"14","author":"Mimori T","year":"2012","unstructured":"Mimori T, Nakashima R, Hosono Y. Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment. Curr Rheumatol Rep. 2012, 14:264-74. 10.1007\/s11926-012-0246-6","journal-title":"Curr Rheumatol Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-007-0553-3","article-title":"Step-up versus primary intensive approach to the treatment of interstitial pneumonia associated with dermatomyositis\/polymyositis: a retrospective study","volume":"17","author":"Takada K","year":"2007","unstructured":"Takada K, Kishi J, Miyasaka N. Step-up versus primary intensive approach to the treatment of interstitial pneumonia associated with dermatomyositis\/polymyositis: a retrospective study. Mod Rheumatol. 2007, 17:123-30. 10.1007\/s10165-007-0553-3","journal-title":"Mod Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0731-7","article-title":"Management of interstitial lung disease in patients with myositis specific autoantibodies","volume":"20","author":"Mecoli CA","year":"2018","unstructured":"Mecoli CA, Christopher-Stine L. Management of interstitial lung disease in patients with myositis specific autoantibodies. Curr Rheumatol Rep. 2018, 20:27. 10.1007\/s11926-018-0731-7","journal-title":"Curr Rheumatol Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-5-199309010-00003","article-title":"Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy","volume":"119","author":"Boumpas DT","year":"1993","unstructured":"Boumpas DT, Austin HA 3rd, Vaughan EM, Yarboro CH, Klippel JH, Balow JE. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med. 1993, 119:366-9. 10.7326\/0003-4819-119-5-199309010-00003","journal-title":"Ann Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2012.01.001","article-title":"Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome","volume":"106","author":"Marie I","year":"2012","unstructured":"Marie I, Dominique S, Janvresse A, Levesque H, Menard JF. Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome. Respir Med. 2012, 106:581-7. 10.1016\/j.rmed.2012.01.001","journal-title":"Respir Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev004","article-title":"Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease","volume":"54","author":"Andersson H","year":"2015","unstructured":"Andersson H, Sem M, Lund MB, et al.. Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease. Rheumatology (Oxford). 2015, 54:1420-8. 10.1093\/rheumatology\/kev004","journal-title":"Rheumatology (Oxford)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/178316-antisynthetase-syndrome-with-predominant-pulmonary-involvement-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:14Z","timestamp":1707508514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/178316-antisynthetase-syndrome-with-predominant-pulmonary-involvement-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,23]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.43966","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,23]]}}}